VarCov Co’s Zymeworks ZYME Stock Holding History

VarCov Co’s Portfolio ZYME Stock Details ZYME Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-9,818	Closed	-$259K	–	666
2025 Q4	$259K	Buy	+9,818	New	+$214K	0.1%	346

Other funds holding ZYME

EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return

RCMNY

Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return

Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

BNP Paribas Asset Management Paris, France $99.8B AUM 45.22% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

VarCov Co's ZYME Position: Q1 2026 in Review

VarCov Co sold out of Zymeworks (ZYME) in Q1 2026, closing a stake of 9,818 shares — an estimated $259K sold.

VarCov Co first reported a position in ZYME in Q4 2025 and held it in 1 quarter. The position peaked at $259K in Q4 2025. 211 funds tracked by Wall St. Rank hold ZYME as of Q1 2026.

VarCov Co reported no remaining Zymeworks position as of Q1 2026 after selling out during the quarter.
VarCov Co sold 9,818 Zymeworks shares in Q1 2026, an estimated $259K.
VarCov Co first reported a position in Zymeworks in Q4 2025 and held it in 1 quarter.
VarCov Co's Zymeworks position peaked at $259K in Q4 2025.
211 funds tracked by Wall St. Rank held Zymeworks as of Q1 2026.

Based on VarCov Co's 13F filing for Q1 2026, filed 15 May 2026.